Seminar  |  18.01.2021, 15:00

TIME Kolloquium

Virginia Herbst (TUM), Maren Mickeler (LMU ISTO) (auf Einladung)


Online-Veranstaltung

Innovation under regulatory uncertainty and the role of expectations: Evidence from the U.S. drone market
Presenter: Virginia Herbst (TUM)
Discussant: Lucy Xialou Wang (Max-Planck-Institut für Innovation und Wettbewerb)


There and back again: Disruptive transitions in dyadic role relationships
Presenter: Maren Mickeler (LMU ISTO)
Discussant: Daniel Obermeier (TUM)

Workshop  |  17.12.2020, 09:00  –  18.12.2020, 16:00

RISE – 3rd Research on Innovation, Science and Entrepreneurship Workshop

Keynote: Rosemarie Ziedonis (Boston University & NBER)

On 17/18 December 2020, the Max Planck Institute for Innovation and Competition will host the 3rd Research on Innovation, Science and Entrepreneurship Workshop, an annual workshop for Ph.D. students and Junior Post-docs in Economics and Management.


The goal of the RISE3 Workshop is to stimulate an in-depth discussion of a select number of empirical research papers. It offers Ph.D. students and Junior Post-docs an opportunity to present their work and to receive feedback.


Keynote speaker of the RISE3 Workshop is Rosemarie Ziedonis (Boston University & NBER).


Get the Program here.
See RISE Workshop.

Seminar  |  09.12.2020 | 15:00  –  16:15

Innovation & Entrepreneurship Seminar: COVID-19 Disruptions Disproportionately Affect Female Academics

Olga Shurchkov (Wellesley College)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

The rapid spread of the COVID-19 pandemic and the subsequent counter-measures, such as school closures, shift to working from home, and social distancing are disrupting economic activity around the world.  As with other major economic shocks, there are winners and losers, leading to increased inequality across certain groups.  In this project, we investigate the effects of COVID-19 on the gender gap in productivity among academics. First, we track the patterns of publications and working paper series submissions of male and female authors before and after COVID-19, performing a simple difference-in-difference analysis to see whether the trends diverge after COVID-19. Preliminary findings from economics suggest that female economists experienced significant declines in submissions in the early months of the pandemic, relative to the mean.  Second, we conduct a broad survey of academics across various disciplines to collect more nuanced data on the respondents’ circumstances, such as spouse employment, the number and age of children, and time use. We find that female academics, particularly those who have children, report a disproportionate reduction in time dedicated to research relative to comparable men and women without children.  Both men and women report substantial increases in childcare and housework burdens, but women experienced significantly larger increases relative to men.


Ansprechpartnerin: Marina Chugunova

Tagung  |  07.12.2020 | 09:05  –  18:00

International Conference on Trade Secret Protection — Asia at a Crossroads

Ort: College of Law, National Taiwan University, Taiwan

Organisatoren:

  • Applied Research Center for Intellectual Assets and the Law in Asia (ARCIALA), School of Law, Singapore Management University (SMU),
  • Max-Planck -Institut für Innovation und Wettbewerb,
  • Center for Law, Technology and Ethics, College of Law, National Taiwan University,
  • Taiwan Intellectual Property Law Association (TIPLA)

Programm zum Download

Seminar  |  02.12.2020 | 15:00  –  16:15

Innovation & Entrepreneurship Seminar: Is the Patent System an Even Playing Field?

Gaétan de Rassenfosse (École Polytechnique Fédérale de Lausanne)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

The patent system underpins the business model of some of the fastest-growing companies. Used appropriately, it should support frontier technologies and nurture new firms. Used perniciously, it can stifle innovation and protect established technological behemoths. We analyze patent examination decisions at the American, European, Japanese, Korean, and Chinese patent offices and find evidence that patent attorneys have a surprisingly significant role in the patent system. Our results suggest that some forces within the examination system maintain the uneven playing field by allocating monopoly rights to inventors with better access to influential attorneys, rather than leveling it by favoring inventors with better, non-obvious ideas. Attorney quality is most important, vis-à-vis invention quality, in less codified and more rapidly changing technology areas such as software and ICT. Moreover, attorney quality is more important when invention quality is low. 


Ansprechpartnerin: Marina Chugunova

Seminar  |  25.11.2020 | 15:00  –  16:15

Innovation & Entrepreneurship Seminar: Global Mobile Inventors

Ernest Miguelez (CNRS-GREThA, Université de Bordeaux)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

We present a comprehensive study on the dynamics of knowledge production and diffusion linked to global mobile inventors (GMIs). We find that GMIs are essential team members of the first few patents in technology classes new to the country of residence as compared to patents filed at later stages. We interpret these results as tangible evidence of GMIs facilitating the technology-specific diffusion of knowledge across nations. (Joint work with Dany Bahar, Brookings Institution, and Prithwiraj Choudhury, Harvard Business School)


Ansprechpartner: Rainer Widmann

Seminar  |  11.11.2020 | 16:30  –  17:45

Innovation & Entrepreneurship Seminar: Product Recalls and New Product Development – Own Firm Distractions and Competitor Firm Opportunities

Ariel D. Stern (Harvard Business School)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

Product recalls create significant challenges for R&D intensive firms, but simultaneously generate potentially lucrative opportunities for competitors. Using the U.S. medical device industry as our setting, we develop predictions and provide evidence that own firm recalls slow new product development activities, while competitor firm recalls accelerate them. We also examine two firm-level moderators that influence the recall and new product development relationship: product scope and ownership structure. We find that own firm recalls slow new product development for all firm types: a single own firm recall slows new product development up to 43 days, equating to more than $10 million in revenue lost in this high-margin and highly competitive setting. We also find that competitor firm recalls are associated with accelerated development times, but only for broad (vs. narrow) product scope firms and public (vs. private) firms. A one standard deviation increase in competitor firm recalls for these firm types accelerates new product development by more than two weeks. Organizational resources and financial incentives are thus key determinants of whether firms can effectively capitalize on the potential market opportunities created by competitor recalls. In post-hoc analyses, we explore whether future product quality is predicted by post-recall submission times, but find no evidence for this relationship. This result suggests that new product development delays following own firm recalls are more likely driven by organizational distractions than by product quality learning, and that firms react strategically and rationally by speeding new products to market after competitor recalls.


Ansprechpartner: Dennis Byrski

Seminar  |  04.11.2020 | 16:00  –  17:15

Innovation & Entrepreneurship Seminar: Innovative Ideas and Gender Inequality

Marlène Koffi (University of Toronto)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

This paper analyzes the recognition of women’s innovative ideas. Bibliometric data from research in economics are used to investigate gender biases in citation patterns. Based on deep learning and machine learning techniques, one can (1) establish the similarities between papers (2) build a link between articles by identifying the papers citing, cited and that should be cited. This study finds that, on average, a paper omits almost half of related prior papers. There are, however, substantial heterogeneities among the authors. In fact, omitted papers are 15% to 30% more likely to be female-authored than male-authored. First, the most likely to be omitted are papers written by women (solo, mostly female team) working at mid-tier institutions, publishing in non-top journals. In a group of related papers, the probability of omission of those papers increases by 6 percentage points compared to men in similar affiliation when the citing authors are only males. Overall, for similar papers, having at least one female author reduces the probability of omitting other women’s papers by up to 10 percentage points, whereas having only male authors increases the probability of being omitted by almost 4 percentage points. Second, the omission bias is twice as high in theoretical fields that involve mathematical economics than it is in applied fields such as education and health economics. Third, men benefit twice as much as women from publishing in a top journal, in terms of likelihood of being omitted. Lastly, being omitted with respect to past publications affects future productivity and reduces the probability of getting published in a top journal. Finally, peer effects and more editorial board diversity tend to counteract and reduce the omission bias.


Ansprechpartnerin: Marina Chugunova

Seminar  |  28.10.2020 | 13:00  –  14:15

Innovation & Entrepreneurship Seminar: Sampling Bias in Entrepreneurial Experiments

Ramana Nanda (Harvard Business School)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

Using data from a prominent online platform for launching new digital products, we document that the composition of the platform’s ‘beta testers’ on the day a new product is launched has a systematic and persistent impact on the new product’s success. Specifically, we use word embedding methods to classify products launched on this platform as more or less focused on the needs of women customers, and show that female-focused products launched on a typical day – when the majority of beta testers are male – experience 30% less growth and are 3.5 percentage points less likely to be operating a year after launch. Exploiting exogenous variation in the composition of users who visit the platform we find that this product gender gap shrinks to zero on days when more female beta testers are present on the website, suggesting that it is the composition of early users, rather than unobserved differences in the growth potential of products catering to women, that is driving our results. Our findings highlight the importance of understanding sampling bias in entrepreneurial experiments and how such bias may lead to a dearth of innovations aimed at consumers who are underrepresented among early-users. (Joint work with Rembrand Koning and Ruiqing Cao)


Ansprechpartner: Rainer Widmann

Seminar  |  21.10.2020 | 15:00  –  16:15

Innovation & Entrepreneurship Seminar: A Prescription for Rising Drug Prices – Enhanced Patent Examination

Melissa Wasserman (UT Austin) und Michael Frakes (Duke University)


Seminare finden derzeit im Online-Format statt (siehe Seminarseite).

The debate surrounding escalating prescription drug prices has increasingly focused on the legitimacy of the practice of brand-name manufacturers receiving patent protection on peripheral features of the drug such as the route of administration, as opposed to just the active-ingredient itself. The key question is whether these later-obtained, secondary patents protect novel features and represent true innovation or, instead, provide little to no innovative benefit and improperly delay generic entry. In this paper, we explore how the Patent Office may improve the quality of the secondary patents issued – thereby reducing the degree of unnecessary and harmful delays of generic entry – by giving examiners more time to review patent applications. Our findings suggest that current examiner time allocations are causing patent examiners to issue low quality secondary patents on the margin. We further set forth evidence suggesting that the costs to investing in greater ex ante scrutiny of secondary pharmaceutical patent applications by the Patent Office are greatly outweighed by the benefits, which include the avoidance of downstream litigation expenses and gains to consumer and total surplus from reduced drug prices.


Ansprechpartnerin: Lucy Xiaolu Wang